ProShare Advisors’s UroGen Pharma URGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,279
| Closed | -$114K | – | 2191 |
|
|
2025
Q1 | $114K | Sell |
10,279
-2,616
| -20% | -$28.9K | ﹤0.01% | 1809 |
|
|
2024
Q4 | $137K | Buy |
+12,895
| New | +$137K | ﹤0.01% | 1997 |
|
|
2024
Q3 | – | Sell |
-11,888
| Closed | -$199K | – | 2109 |
|
|
2024
Q2 | $199K | Buy |
+11,888
| New | +$199K | ﹤0.01% | 1531 |
|
|
2020
Q1 | – | Sell |
-7,077
| Closed | -$236K | – | 1572 |
|
|
2019
Q4 | $236K | Buy |
+7,077
| New | +$236K | ﹤0.01% | 1487 |
|
|
2019
Q3 | – | Sell |
-6,068
| Closed | -$218K | – | 1694 |
|
|
2019
Q2 | $218K | Sell |
6,068
-887
| -13% | -$31.9K | ﹤0.01% | 1392 |
|
|
2019
Q1 | $257K | Buy |
6,955
+1,710
| +33% | +$63.2K | ﹤0.01% | 1336 |
|
|
2018
Q4 | $226K | Buy |
+5,245
| New | +$226K | ﹤0.01% | 1306 |
|